# Phase 2 Marijuana Abuse trials recruiting: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in phase 2 for Marijuana Abuse that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Marijuana Abuse trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/marijuana-abuse

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 16, 2026 | NCT07878130 | An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid... | King's College London | Phase 2 | Not yet recruiting | None Volunteer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878130) |
| August 25, 2026 | NCT07783555 | Varenicline as a Treatment for Cannabis Use Disorder | Medical University of South Carolina | Phase 2 | Not yet recruiting | Cannabis Abuse | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783555) |
| July 21, 2026 | NCT07715864 | Naturally Produced Cannabinoids for Neuroprotection From Concussion | University of Regina | Phase 2 | Recruiting | Healthy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715864) |
| April 24, 2026 | NCT07549256 | Cannabidiol for Pain Relief of Patients With End-stage mCRPC | Regionshospital Nordjylland | Phase 2 | Recruiting | Metastatic Castration Resistant Prostate Cancer (mCRPC) | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07549256) |
| April 13, 2026 | NCT07523633 | Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder | Sponsor not shown (see the record) | Phase 2 | Recruiting | Cannabis Use Disorder, Cannabis Use Disorders, Cannabis Abuse, Cannabis Dependence, Cannabis Addiction | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523633) |
| March 12, 2026 | NCT07468552 | Trial of Tirzepatide for the Treatment of Cannabis Use Disorder | National Institute on Drug Abuse (NIDA) | Phase 2 | Not yet recruiting | Cannabis Use Disorder | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468552) |
| November 5, 2025 | NCT07224932 | Tolerability and Efficacy of CBD Extract for RLS Treatment | University of Colorado, Denver | Phase 2 | Not yet recruiting | Restless Leg Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224932) |
| November 5, 2025 | NCT07224698 | Inhaled Cannabis for Treatment of PTSD | Multidisciplinary Association for Psychedelic Studies | Phase 2 | Not yet recruiting | Post Traumatic Stress Disorder PTSD | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224698) |
| October 14, 2025 | NCT07216690 | Pregnenolone as a Treatment for Cannabis Intoxication | Johns Hopkins University | Phase 2 | Recruiting | Cannabis Intoxication | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216690) |
| June 17, 2025 | NCT07023744 | CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children | University of Manitoba | Phase 2 | Not yet recruiting | Drug Resistant Epilepsy | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07023744) |
| April 27, 2025 | NCT06946940 | Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia | Rambam Health Care Campus | Phase 2 | Recruiting | Fibromyalgia | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946940) |
| October 8, 2024 | NCT06629389 | Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms | Laboratorio Elea Phoenix S.A. | Phase 2 | Recruiting | Parkinson Disease | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06629389) |
| July 29, 2024 | NCT06526208 | Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults | Southwest Autism Research & Resource Center | Phase 2 | Recruiting | Autism Spectrum Disorder, Anxiety | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06526208) |
| July 24, 2024 | NCT06518434 | A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients | University Medical Center Groningen | Phase 2 | Recruiting | Hepatocellular Carcinoma, Cannabis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06518434) |
| February 15, 2024 | NCT06261489 | Cannabis (THC vs. CBD) in Multiple Sclerosis | University of Calgary | Phase 2 | Recruiting | Multiple Sclerosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06261489) |
| August 21, 2023 | NCT05999383 | Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration | University of California, San Francisco | Phase 2 | Recruiting | THC, Cannabis, Cannabis Use, Cannabis Smoking, Tobacco Use, Vaping | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05999383) |
| August 14, 2023 | NCT05985850 | Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy | BC Centre on Substance Use | Phase 2 | Recruiting | Opioid Use Disorder, Methadone, Cannabis, Fentanyl | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05985850) |
| April 20, 2023 | NCT05822362 | CBD for Individuals at Risk for Alzheimer's Disease | University of Colorado, Denver | Phase 2 | Recruiting | Mild Cognitive Impairment | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05822362) |
| August 25, 2022 | NCT05514899 | Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV | University of California, San Diego | Phase 2 | Recruiting | HIV, Cannabis, THC, Neuroinflammatory Disease, Neuroinflammatory Response, Microbiome | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05514899) |
| May 25, 2022 | NCT05389930 | Cannabis' Impact on Alcohol Consumption | Brown University | Phase 2 | Recruiting | Alcohol Drinking, Cannabis Use, Cannabis, Alcohol Use Disorder | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05389930) |
| April 20, 2022 | NCT05337033 | Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial | University of Manitoba | Phase 2 | Recruiting | Chronic Migraine | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05337033) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Colorado, Denver | 2 |
| University of Manitoba | 2 |
| Multidisciplinary Association for Psychedelic Studies | 1 |
| Laboratorio Elea Phoenix S.A. | 1 |
| BC Centre on Substance Use | 1 |
| Brown University | 1 |
| Rambam Health Care Campus | 1 |
| Southwest Autism Research & Resource Center | 1 |
| University of Regina | 1 |
| Johns Hopkins University | 1 |
| University of California, San Francisco | 1 |
| Regionshospital Nordjylland | 1 |
| National Institute on Drug Abuse (NIDA) | 1 |
| University of Calgary | 1 |
| University Medical Center Groningen | 1 |
| University of California, San Diego | 1 |
| King's College London | 1 |
| Medical University of South Carolina | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| Canada | 4 |
| Denmark | 2 |
| Argentina | 1 |
| Israel | 1 |
| Netherlands | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Ecuadorian restaurants in the United States](https://specstream.ai/data/businesses/ecuadorian-restaurants/united-states)
- [Specialty hospitals in the United States](https://specstream.ai/data/businesses/specialty-hospitals/united-states)
- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
- [TV service providers in the United States](https://specstream.ai/data/businesses/tv-service-providers/united-states)
- [Hotel supply companies in the United States](https://specstream.ai/data/businesses/hotel-supply-companies/united-states)
- [Aircraft manufacturers in the United States](https://specstream.ai/data/businesses/aircraft-manufacturers/united-states)
